3-Fluorotoluene | CAS:352-70-5

We serve 3-Fluorotoluene CAS:352-70-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Fluorotoluene

Chemical Name:3-Fluorotoluene
CAS.NO:352-70-5
Synonyms:3-Fluorotoluene
3-fluoro-1-methylbenzene
m-Fluorotoluene
1-Fluoro-3-methylbenzene
1-Methyl-3-fluorobenzene
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 118.2±9.0 °C at 760 mmHg
Melting Point -87 °C
Molecular Formula C7H7F
Molecular Weight 110.129
Flash Point 9.4±0.0 °C
Vapour Pressure 20.1±0.2 mmHg at 25°C
Index of Refraction 1.477
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Fluorotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Methyl-3-fluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Fluorotoluene Use and application,m-Fluorotoluene technical grade,usp/ep/jp grade.


Related News: Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23.(6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-ACETONITRILE manufacturer Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association.4-nitrophenol supplier There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.2,5-Dichloro-4-aminophenol vendor There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.